market-trends is the sole category represented across all 1 tracked stories. The Age is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Brisbane Times
market-trends is the sole category represented across all 1 tracked stories. The Age is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 3.1 for the same window. The 7 average consequence score is above the beat benchmark of 6.3 in the same window. Brisbane Times appears in 1 tracked Healthcare story from March 17, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 34 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Brisbane Times. Shared-story counts are live from our verified record — not editorial picks.
A landmark study published in The Lancet has concluded that medicinal cannabis is no more effective than a placebo in treating anxiety, depression, and PTSD. The findings challenge the multi-billion dollar cannabis industry's reliance on mental health prescriptions and could trigger significant regulatory shifts.